Biotechnology in Europe

Biotechnology

Publication Date	September 2009
Publisher	Datamonitor
Product Type	Report
Pages	31
ISBN Number	not applicable
Product Code	DAT00627

Buy this product or for assistance call +44 20 7060 7474

PDF £150.00$250 | €168

FAX Order above formats by FAX

Summary

Datamonitor's Biotechnology in Europe industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by value and/or volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2008 annual average exchange rates.

For the purpose of this report Europe is deemed to comprise of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom.

The global figure is deemed to comprise of the Americas, Asia-Pacific and Europe.

The Americas comprises Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

Content

Executive Summary
Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
Chapter 2 Market Value
Chapter 3 Market Segmentation I
Chapter 4 Market Segmentation Ii
Chapter 5 Five Forces Analysis
- 5.1 Summary
- 5.2 Buyer Power
- 5.3 Supplier Power
- 5.4 New Entrants
- 5.5 Substitutes
- 5.6 Rivalry
Chapter 6 Leading Companies
- 6.1 UCB Group
- 6.2 Merck KGaA
- 6.3 Innogenetics N V
- 6.4 Amgen Inc
Chapter 7 Market Forecasts
- 7.1 Market Value Forecast
Chapter 8 Macroeconomic Indicators
Chapter 9 Appendix
- 9.1 Methodology
- 9.2 Industry Associations
- 9.3 Related Datamonitor Research
List of Tables
- Table 1: Europe Biotechnology Market Value: $ billion, 2004-2008
- Table 2: Europe Biotechnology Market Segmentation I: % Share, by Value, 2008
- Table 3: Europe Biotechnology Market Segmentation II: % Share, by Value, 2008
- Table 4: Key Facts: UCB Group
- Table 5: Key Financials: UCB Group
- Table 6: Key Facts: Merck KGaA
- Table 7: Key Financials: Merck KGaA
- Table 8: Key Facts: Innogenetics N V
- Table 9: Key Financials: Innogenetics N V
- Table 10: Key Facts: Amgen Inc
- Table 11: Key Financials: Amgen Inc
- Table 12: Europe Biotechnology Market Value Forecast: $ billion, 2008-2013
- Table 13: Europe Exchange Rate, 2004-2008